Oligodendroglial component complicates the prediction of tumour grading with metabolic imaging

[1]  F. Rodriguez,et al.  Diagnostic Pathology: Neuropathology , 2016 .

[2]  H. Iseki,et al.  11C-Methionine Uptake Correlates with Combined 1p and 19q Loss of Heterozygosity in Oligodendroglial Tumors , 2013, American Journal of Neuroradiology.

[3]  B. Scheithauer,et al.  Diagnostic Pathology: Neuropathology , 2012 .

[4]  K. Houkin,et al.  18F-Fluoromisonidazole positron emission tomography may differentiate glioblastoma multiforme from less malignant gliomas , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[5]  Y. Iwadate,et al.  Discrimination between low-grade oligodendrogliomas and diffuse astrocytoma with the aid of 11C-methionine positron emission tomography. , 2011, Journal of neurosurgery.

[6]  F. Berthold,et al.  [11C]-l-Methionine positron emission tomography in the management of children and young adults with brain tumors , 2009, Journal of Neuro-Oncology.

[7]  Tadashi Nariai,et al.  Contributions of biological tumor parameters to the incorporation rate of l-[methyl-11C] methionine into astrocytomas and oligodendrogliomas , 2009, Journal of Neuro-Oncology.

[8]  Y Muragaki,et al.  Analysis of 11C-methionine Uptake in Low-Grade Gliomas and Correlation with Proliferative Activity , 2008, American Journal of Neuroradiology.

[9]  N. Kawai,et al.  11C-Acetate PET in the Evaluation of Brain Glioma: Comparison with 11C-Methionine and 18F-FDG-PET , 2008, Molecular Imaging and Biology.

[10]  T Metens,et al.  Stereotactic comparison among cerebral blood volume, methionine uptake, and histopathology in brain glioma. , 2007, AJNR. American journal of neuroradiology.

[11]  L. Mortelmans,et al.  [11C]methionine PET, histopathology, and survival in primary brain tumors and recurrence. , 2006, AJNR. American journal of neuroradiology.

[12]  Olivier Dewitte,et al.  Integrated positron emission tomography and magnetic resonance imaging-guided resection of brain tumors: a report of 103 consecutive procedures. , 2006, Journal of neurosurgery.

[13]  Joji Kawabe,et al.  Correlation of amino-acid uptake using methionine PET and histological classifications in various gliomas , 2005, Annals of nuclear medicine.

[14]  Tadashi Nariai,et al.  Usefulness of L-[methyl-11C] methionine-positron emission tomography as a biological monitoring tool in the treatment of glioma. , 2005, Journal of neurosurgery.

[15]  Jae Jeong,et al.  Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18F-FDG PET , 2002, European Journal of Nuclear Medicine and Molecular Imaging.

[16]  O. Witte,et al.  Positron emission tomography with injection of methionine as a prognostic factor in glioma. , 2001, Journal of neurosurgery.

[17]  G. Fuller,et al.  Limitations of stereotactic biopsy in the initial management of gliomas. , 2001, Neuro-oncology.

[18]  R A Betensky,et al.  Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[19]  N. Kuwata,et al.  Evaluation of the malignancy of glioma using 11C-methionine positron emission tomography and proliferating cell nuclear antigen staining , 1999, Neurosurgical Review.

[20]  M. Sasaki,et al.  A comparative study of thallium-201 SPET, carbon-11 methionine PET and fluorine-18 fluorodeoxyglucose PET for the differentiation of astrocytic tumours , 1998, European Journal of Nuclear Medicine.

[21]  A. Thiel,et al.  11C-methionine PET for differential diagnosis of low-grade gliomas , 1998, Neurology.

[22]  Adle‐Biassette,et al.  Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the vasculature of oligodendrogliomas , 1998, Neuropathology and applied neurobiology.

[23]  M P Sandler,et al.  Rest myocardial perfusion/metabolism imaging using simultaneous dual-isotope acquisition SPECT with technetium-99m-MIBI/fluorine-18-FDG. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[24]  S. Coons,et al.  Regional heterogeneity in the DNA content of human gliomas , 1993, Cancer.

[25]  W. Dahnert.  Comprar Radiology review manual (international edition) | W. Dahnert | 9781451118124 | Lippincott Williams & Wilkins , 2011 .

[26]  T. Shiga,et al.  Detection of histological anaplasia in gliomas with oligodendroglial components using positron emission tomography with 18F-FDG and 11C-methionine: report of two cases , 2010, Journal of Neuro-Oncology.

[27]  Sungeun Kim,et al.  11C-methionine PET as a prognostic marker in patients with glioma: comparison with 18F-FDG PET , 2004, European Journal of Nuclear Medicine and Molecular Imaging.